Skip to main content
. 2017 May 6;5:97–104. doi: 10.1016/j.omto.2017.05.001

Figure 4.

Figure 4

Survival Analysis in Immunocompetent and Immunodeficient Murine Glioma Models Infected with Either Replication-Competent or Replication-Incompetent Adenoviral Vectors

(A) Immunocompetent or (B) immunodeficient mice bearing intracranial GL261-OVA were treated intracranially (i.c.) with either replication-incompetent Ad5RGD-CMV-GFP or replication-competent Ad5RGD-CMV-Δ24 5 days after tumor implantation. Kaplan-Meier survival curves of treated mice were calculated. *p < 0.05, **p < 0.01, and ***p < 0.001.